Aeglea BioTherapeutics Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (16)

Latest Posts

About This Stock More About This Stock
Aeglea BioTherapeutics Prices Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Tuesday, June 6, 2017 11:28 AM EDT
Aeglea BioTherapeutics, Inc., today announced the pricing of its underwritten public offering of 3,000,000 shares of common stock at a public offering price of $4.10 per share, with expected gross proceeds to Aeglea of $12.3 million.
In this article: AGLE
Read
Aeglea BioTherapeutics Announces Proposed Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Monday, June 5, 2017 5:02 PM EDT
Aeglea BioTherapeutics, Inc., today announced that it has commenced an underwritten public offering of common stock.
In this article: AGLE
Read
Aeglea Biotherapeutics IPO: Wait For Larger April Deals
Article By: Don Dion
Monday, April 4, 2016 10:39 PM EDT
Aeglea Biotherapeutics Inc. expects to raise $51.4 million in its upcoming IPO. Based in Austin, Texas, Aeglea Biotherapeutics is a biotechnology company developing enzyme-based therapeutics to treat disorders of metabolism and cancer.
In this article: AGLE Also: AZN, BMY, JNJ, LLY, NVS, AMGN, CELG
Read
Premarket Biotech Digest 2016-03-29: ACAD Nuplazid Review, APRI Tumbles, PBYI Delays NDA Filing
Article By: KKD Healthcare Analytics
Tuesday, March 29, 2016 8:31 AM EDT
Daily premarket biotech digest
In this article: ACAD, ALDR, EGRX, AXSM, BPMX, PBYI, AERI, APRI, AGLE
Read

PARTNER HEADLINES

Latest Tweets for $AGLE

No tweets yet!